SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer’s Disease
ROCKVILLE, Md. , Jan. 12, 2026 /PRNewswire/ — SciNeuro Pharmaceuticals Logo (PRNewsfoto/SciNeuro Pharmaceuticals) SciNeuro grants Novartis an exclusive worldwide…